B: related compounds D5 and D6 did not inhibit PknD at 1 or 10 μM. C: 1 mM DTT and 1% Triton X-100 did not decrease inhibition of PknD by compound D7 (used at 10 μM in all panels). DMSO (0.1%) is shown as control. D: compound D7 inhibited phosphorylation of the FHA-2 domain (32P-His-FHA-2) of CdsD by PknD. Western blotting showed equivalent amounts of protein in each autoradiograph (lower panels). Compound D7 is ATP competitive and therefore it has the potential to inhibit other chlamydial enzymes that utilize ATP as a substrate. To determine if compound D7 could

inhibit a chlamydial ATPase, we examined its effect on the activity of CdsN, the T3SS ATPase of C. pneumoniae [47]. The activity of CdsN was 0.51 ± 0.09 and 0.43 ± 0.06 micromoles of phosphate/min/mg protein in the CFTRinh-172 concentration presence of 5 μM and 100 μM of compound D7, respectively, compared with 0.46 ± 0.04 in the absence of compound D7. Compound D7 selleck products did not inhibit CdsN activity suggesting that it may not be a broad spectrum inhibitor of enzymes that utilize ATP as a substrate. To assess

whether compound D7 could be used in cell culture we first exposed the compound to reducing conditions similar to that found in eukaryotic cells, then tested its ability to inhibit PknD. Equivalent volumes of compound D7 (100 μM) and DTT BAY 63-2521 concentration (2 mM) were mixed on ice for 15 minutes prior to testing in the kinase assay. Compound D7 retained the ability to inhibit PknD autophosphorylation (fig. 1C) after exposure

to DTT, suggesting that it would not have decreased effectiveness under the reducing conditions of the cell cytoplasm. To rule out the possibility that the inhibitory effect of D7 was due to aggregates of the compound, we tested for inhibitory Dichloromethane dehalogenase activity in the presence of 1% Triton X-100 to reduce potential aggregates. Compound D7 retained efficacy toward PknD in the presence of 1% Triton X-100 (fig. 1C), indicating that the inhibition was not due to a non-specific effect of compound D7 aggregates. We recently identified CdsD, an ortholog of Yersinia YscD, as a substrate of PknD and showed that PknD phosphorylated 2 FHA domains of CdsD [45]. We therefore examined whether compound D7 could block phosphorylation of CdsD by PknD. Compound D7 completely blocked the phosphorylation of the CdsD FHA-2 domain by PknD (fig. 1D) indicating that, in addition to inhibiting PknD autophosphorylation, it also inhibits phosphorylation of CdsD. Effect of compound D7 on the growth of C. pneumoniae in HeLa cells The identification of a PknD inhibitor provides a new tool to study the role of PknD in the developmental cycle of C. pneumoniae. Since PknD may play a role at various times throughout the 72 hour developmental cycle we tested the effect of several compounds including compound D7 on the growth of C. pneumoniae in cell culture. Compounds were added to the cell culture media 1 hr prior to infection with C.